|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.200 USD | +0.39% |
|
+4.00% | +7.66% |
| 06-30 | Relmada Therapeutics, Inc.(NasdaqCM:RLMD) added to Russell Small Cap Comp Growth Benchmark | CI |
| 06-29 | Relmada Therapeutics, Inc.(NasdaqCM:RLMD) added to Russell 2500 Growth Benchmark | CI |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Neutral | Bullish |
| Resistance | 5.72 | 7.86 | 7.64 |
| Spread/Res. | -9.09% | -33.84% | -31.94% |
| Spread/Supp. | +4.00% | +46.48% | +124.14% |
| Support | 5 | 3.55 | 2.32 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- RLMD Stock
- Charts Relmada Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
